Merck will ask “as soon as possible” for emergency clearance in the United States for the first anti-Covid pill. Clinical tests conducted – says the pharmaceutical giant – have shown that the oral drug reduces the risk of hospitalizations and deaths when administered to high-risk people in the early stages of infection. The Merck pill, developed to stop the coronavirus from replicating, is taken for five days, four tablets a day. Merck flies to Wall Street. Stocks are up 12%, in what is the biggest jump since 2009.
REPRODUCTION RESERVED © Copyright ANSA